Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Randomized Controlled Trial

Clinical Trial

Research Support, Non-U.S. Gov't

Comparative Study

Multicenter Study

Controlled Clinical Trial

Review

Case Reports

Clinical Trial, Phase IV

Observational Study

Publication Year

From

Quick links

Individual year

2026

2023

2021

2019

2018

2017

2014

2013

2012

2010

2009

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Nadroparin""[mesh_terms]

30 Results

Searching titles within these results

Low molecular weight heparin treatment in steroid refractory ulcerative colitis: clinical outcome and influence on mucosal capillary thrombi.

A A Vrij, J M Jansen, E J Schoon, A de Bruïne, H C Hemker, R W Stockbrügger

Scandinavian journal of gastroenterology. Supplement 2002

Full Text

Abstract

Tolerability of percutaneous coronary interventions in patients receiving nadroparin calcium for unstable angina or non-Q-wave myocardial infarction: the Angiofrax study.

Jaroslaw Wójcik, Leonardo Bolognese, Armando Bethencourt, Christian Berthe, Jean-Pierre Bassand

Current medical research and opinion 2003;19(2):107-13

Full Text

Abstract

Calcifying panniculitis following subcutaneous injections of nadroparin-calcium in a patient with osteomalacia.

A Campanelli, G Kaya, I Masouyé, L Borradori

The British journal of dermatology 2005;153(3):657-60

Full Text

Abstract

Efficacy and safety of weight-adapted nadroparin calcium vs. heparin sodium in prevention of clinically evident thromboembolic complications in 1,190 general surgical patients.

B Egger, S W Schmid, M Naef, S Wildi, M W Büchler

Digestive surgery 2001;17(6):602-609

Full Text

Abstract

Anticoagulation therapy early is safe in portal vein thrombosis patients with acute variceal bleeding: a multi-centric randomized controlled trial.

Zhanjuan Gao, Shanshan Li, Jingrun Zhao, Jinhou Li, Yanjing Gao

Internal and emergency medicine 2023;18(2):513-521

Full Text

Abstract

Variations of serum potassium level and risk of hyperkalemia in inpatients receiving low-molecular-weight heparin.

Leonardo Cinetto, Giuseppe Gheno, Carmelo Savarino, Sandro Vellar, Maurizio Carraro, Massimo Randon

European journal of clinical pharmacology 2004;59(5-6):373-7

Full Text

Abstract

Formation and Development of Deep Vein Thrombosis in Hip Fracture Patients With and Without Anticoagulation.

Chen Fei, Fan Xu, Wei Fan, Chen Wang, Wu-Qiang Jiang, Zhe Song, Kun Zhang, Peng-Fei Wang

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2026;32():10760296261487841

Full Text

Abstract

Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins.

Filippo Ferrara, Francesco Meli, Corrado Amato, Valentina Cospite, Francesco Raimondi, Giuseppe Novo, Salvatore Novo

Angiology 2006;57(4):418-23

Full Text

Abstract

Citrate anticoagulation for continuous venovenous hemofiltration.

Heleen M Oudemans-van Straaten, Rob J Bosman, Matty Koopmans, Peter H J van der Voort, Jos P J Wester, Johan I van der Spoel, Lea M Dijksman, Durk F Zandstra

Critical care medicine 2009;37(2):545-52

Full Text

Abstract

Influence of Fondaparinux Versus Nadroparin Calcium Thromboprophylaxis on Clinical Parameters Following Total Knee Arthroplasty.

Damjan Dimnjaković, Melita Buljan, Branko Tripković, Ana Aljinović, Domagoj Delimar, Goran Bićanić, Zdravka Mihaljević

Acta clinica Croatica 2017;55(3):414-421

Full Text

Abstract

Use of low molecular weight heparin for prevention of deep vein thrombosis in total knee arthroplasty--a study of its efficacy in an Asian population.

Y K Fong, P Ruban, S J Yeo, B P Lee, N N Lo, K H Seow, S C Ng

Annals of the Academy of Medicine, Singapore 2001;29(4):439-41

Full Text

Abstract

Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.

Silvy Laporte, Herv Decousus, Claire Dutrey-Dupagne, Pierre Fournel, Jean-Philippe Jacquin, Andréa Buchmüller-Cordier, Véronique Charlet, Dominique Mille, Patrick Mismetti

Haematologica 2003;88(1):67-73

Full Text

Abstract

Efficacy of low molecular weight heparin in patients with acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support.

Yongbing Qian, Hui Xie, Rui Tian, Kanglong Yu, Ruilan Wang

COPD 2014;11(2):171-6

Free Full Text

Abstract

Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The Association of Non-University Affiliated Intensive Care Specialist Physicians of France.

F Fraisse, L Holzapfel, J M Couland, G Simonneau, B Bedock, M Feissel, P Herbecq, R Pordes, J F Poussel, L Roux

American journal of respiratory and critical care medicine 2000;161(4 Pt 1):1109-14

Full Text

Abstract

Randomized, prospective trial comparing bridging therapy using low-molecular-weight heparin with maintenance of oral anticoagulation during extraction of teeth.

Branislav V Bajkin, Stevan L Popovic, Srecko D J Selakovic

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 2009;67(5):990-5

Full Text

Abstract

Results: 1 – 15 / 30

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Nadroparin""[mesh_terms]

Low molecular weight heparin treatment in steroid refractory ulcerative colitis: clinical outcome and influence on mucosal capillary thrombi.

Tolerability of percutaneous coronary interventions in patients receiving nadroparin calcium for unstable angina or non-Q-wave myocardial infarction: the Angiofrax study.

Calcifying panniculitis following subcutaneous injections of nadroparin-calcium in a patient with osteomalacia.

Efficacy and safety of weight-adapted nadroparin calcium vs. heparin sodium in prevention of clinically evident thromboembolic complications in 1,190 general surgical patients.

Anticoagulation therapy early is safe in portal vein thrombosis patients with acute variceal bleeding: a multi-centric randomized controlled trial.

Variations of serum potassium level and risk of hyperkalemia in inpatients receiving low-molecular-weight heparin.

Formation and Development of Deep Vein Thrombosis in Hip Fracture Patients With and Without Anticoagulation.

Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins.

Citrate anticoagulation for continuous venovenous hemofiltration.

Influence of Fondaparinux Versus Nadroparin Calcium Thromboprophylaxis on Clinical Parameters Following Total Knee Arthroplasty.

Use of low molecular weight heparin for prevention of deep vein thrombosis in total knee arthroplasty--a study of its efficacy in an Asian population.

Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.

Efficacy of low molecular weight heparin in patients with acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support.

Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The Association of Non-University Affiliated Intensive Care Specialist Physicians of France.

Randomized, prospective trial comparing bridging therapy using low-molecular-weight heparin with maintenance of oral anticoagulation during extraction of teeth.

Results for
""Nadroparin""[mesh_terms]